recommendation for the use of MTX in PMR are the following: 1) the total number of patients investigated in randomized trials was small (n5194) The group recognized that no recommendation can be made for the use of other non-biologic (ie, conventional synthetic and conventional targeted) DMARDs in PMR because of the lack of good evidence from PMR studies. Hydroxychloroquine was investigated by a single very low QoE retrospective study reporting no benefit regarding relapse rate Recommendation